Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (4504)	4/24/2008 5:36:34 PM
From: ~digs	Read Replies (1) \| Respond to of 7944

[NASDAQ:IPHS] INNOPHOS HOLDINGS, INC. > 18.30

To: ~digs who wrote (4504)	5/31/2008 7:24:19 PM
From: ~digs	Respond to of 7944

Innophos Holdings Inc., a manufacturer of specialty phosphates, said Thursday several of its stockholders will offer 4 million of the company's shares in a secondary offering. The company said underwriters will also have the option to buy another 600,000 shares to cover over-allotments, if any. The company added that the price will be determined based on "prevailing market prices." Innophos said it will not get any proceeds from the offering.

To: ~digs who wrote (4504)	8/4/2008 9:05:55 PM
From: ~digs	Respond to of 7944

WASHINGTON (AP) -- Shares of Innophos Holdings Inc. [IPHS] soared to an all-time high Friday, a day after the phosphate manufacturer reported it moved to a better-than-expected profit in the second quarter. After the closing bell Thursday, the Cranbury, N.J.-based company said it earned $59 million, or $2.74 per share, in the three months ending June 30, up from a loss of $5 million, or 25 cents per share, in the year-ago quarter. Sales rose 74 percent to $264 million. The company attributed the gain mostly to higher prices charged in the U.S., Mexico and Canada for its products that are used in fertilizer. Greater demand for fertilizer based on higher food prices have allowed fertilizer producers to substantially raise prices recently. Analysts polled by Thomson Financial expected more modest earnings of 88 cents per share on sales of $211.6 million. For 2008, the company predicted sales of between $695 million to $755 million. It also expects operating income to grow by $80 million in each of the third and fourth quarters. Analysts forecast full-year revenue of $815 million. The company said it expected price growth to remain robust for the rest of the year, potentially outweighing higher costs for the raw materials it uses to make specialty phosphates. Innophos said it should realize the full impact of earlier price hikes by the end of the year. Oppenheimer & Co. analyst Edward Yang, who maintains an "Outperform" rating on the shares, wrote in a research note that the company's outlook is strong. "IPHS continues to indirectly benefit from robust agricultural markets," he wrote, and upped his price target to $47 from $38. That implies upside of 60 percent over its closing price Thursday of $29.37. Company shares were up $8.05, or 27.4 percent, to $37.42 in afternoon trading, after hitting an all-time high of $40.68 earlier in the session. Shares of Innophos -- which went public in 2006 -- have ranged between $10.44 and $35.69 in the past 52 weeks, and are up 97 percent since the start of the year.